![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 9/127 | (2006.01) |
C07C 229/12 | (2006.01) | ||
A61K 31/221 | (2006.01) | ||
C12N 15/113 | (2010.01) | ||
A61K 48/00 | (2006.01) | ||
A61K 47/14 | (2017.01) |
(11) | Number of the document | 2440183 |
(13) | Kind of document | T |
(96) | European patent application number | 10786869.7 |
Date of filing the European patent application | 2010-06-10 | |
(97) | Date of publication of the European application | 2012-04-18 |
(45) | Date of publication and mention of the grant of the patent | 2018-07-18 |
(46) | Date of publication of the claims translation | 2018-08-10 |
(86) | Number | PCT/US2010/038224 |
Date | 2010-06-10 |
(87) | Number | WO 2010/144740 |
Date | 2010-12-16 |
(30) | Number | Date | Country code |
185800 P | 2009-06-10 | US | |
244834 P | 2009-09-22 | US |
(72) |
AKINC, Akin, US
DORKIN, Joseph, R., US
QIN, Xiaojun, US
CANTLEY, William, GB
MANOHARAN, Muthiah, US
RAJEEV, Kallanthottathil, G., US
NARAYANANNAIR, Jayaprakash, K., US
JAYARAMAN, Muthusamy, US
CHEN, Jianxin, US
ANSELL, Steven, US
|
(73) |
Arbutus Biopharma Corporation,
100- 8900 Glenlyon Parkway, Burnaby, BC V5J 5J8,
CA
|
(74) |
Gediminas PRANEVIČIUS,
Advokatų profesinė bendrija IP FORMA, Užupio g. 30, LT-01203 Vilnius,
LT
|
(54) | Patobulinta lipido kompozicija |
IMPROVED LIPID FORMULATION |
Payment date | Validity (years) | Amount | |
2025-04-24 | 16 | 347.00 EUR |
2026-06-10 |